Company Overview of Ambrx, Inc.
Ambrx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of protein-based drugs. The company’s products include ARX-201, a drug candidate, which is used for the treatment of growth hormone deficiencies. Ambrx, Inc. has strategic alliance with Eli Lilly, EMD Serono, and Merck & Company. The company was founded in 2003 and is based in La Jolla, California.
10975 North Torrey Pines Road
La Jolla, CA 92037
Founded in 2003
Key Executives for Ambrx, Inc.
Ambrx, Inc. Key Developments
Similar Private Companies By Industry
|Tetra Discovery Partners LLC||United States|
|Osprey Pharmaceuticals USA, Inc.||United States|
|Nucleico, LLC||United States|
|Reliv', Inc.||United States|
|Arius Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Bridgewater, NJ | InformaticaPosted: Dec 11
- Parsippany, NJ | RGPPosted: Dec 13
- Princeton, NJ | RGPPosted: Nov 27
- Princeton, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact Ambrx, Inc., please visit www.ambrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.